Publications
CER Interview with Alexander Ommaya
| Type: | Podcast |
| Date: | January 5, 2012 |
| Related Topics: | Aging Research, Drug Development, Drug Safety, Medical Innovation, Policy, Research, Vision Loss |
Alexander Ommaya, DSc, MA is Director of Translational Research at the Department of Veterans Affairs. In this role he is responsible for managing development of new research activities focusing on health systems improvements, genomic medicine, text analysis of the VA electronic health record, comparative effectiveness research, traumatic brain injury, and Post Traumatic Stress disorder. Previously he was Director of the Institute of Medicine’s Drug Forum and Clinical Research Roundtable. These multi stakeholder groups addressed science policy issues concerning the research enterprise and established public / private collaborative research activities.
At Blue Cross and Blue Shield of Florida he directed Business Knowledge Management where his department evaluated and developed improvements for pharmacy, disease, and utilization management programs. Dr. Ommaya has worked for the Agency for Healthcare Research and Quality as a Senior Advisor for the Office of the Administrator; Walter Reed Army Medical Center as a Senior Analyst for the Defense and Veteran’s Brain Injury Program; the U.S. Senate as a Health Policy Fellow; and the National Institutes of Mental Health. His previous research focused on neuroplasticity and cortical reorganization; treatment of malignant Glioma; rehabilitation after traumatic brain injury; and health care quality and costs of care. Dr. Ommaya is a member of the Veterans Affairs Technology Assessment Advisory Group and previously the Medicare Coverage Advisory Committee. Dr. Ommaya received his Doctoral degree in Health Policy and Management from Johns Hopkins University; a Master’s degree in Biopsychology from Mount Holyoke College; and his undergraduate degree in Philosophy from Vassar College.
The discussion presented represents the views of Alexander Ommaya, D.Sc., MA, and does not necessarily represent the views of the Department of Veterans Affairs or the United States government. No statement should be construed as an official position of the Department of Veterans Affairs.
At Blue Cross and Blue Shield of Florida he directed Business Knowledge Management where his department evaluated and developed improvements for pharmacy, disease, and utilization management programs. Dr. Ommaya has worked for the Agency for Healthcare Research and Quality as a Senior Advisor for the Office of the Administrator; Walter Reed Army Medical Center as a Senior Analyst for the Defense and Veteran’s Brain Injury Program; the U.S. Senate as a Health Policy Fellow; and the National Institutes of Mental Health. His previous research focused on neuroplasticity and cortical reorganization; treatment of malignant Glioma; rehabilitation after traumatic brain injury; and health care quality and costs of care. Dr. Ommaya is a member of the Veterans Affairs Technology Assessment Advisory Group and previously the Medicare Coverage Advisory Committee. Dr. Ommaya received his Doctoral degree in Health Policy and Management from Johns Hopkins University; a Master’s degree in Biopsychology from Mount Holyoke College; and his undergraduate degree in Philosophy from Vassar College.
“It’s always difficult to change existing practice patterns, and even when the data is published in high-profile scientific journals like the New England Journal, it doesn’t by itself necessarily change practice.”
The discussion presented represents the views of Alexander Ommaya, D.Sc., MA, and does not necessarily represent the views of the Department of Veterans Affairs or the United States government. No statement should be construed as an official position of the Department of Veterans Affairs.
Tweet
This podcast series provides expert reactions to the CATT trial data in terms of what it will mean for wAMD patients and professionals, and its potential impact on future trials, policies and innovation.
To listen to interviews on this topic with other experts, click here.
To listen to interviews on this topic with other experts, click here.
Living Longer and Loving It!
Sign up for the Alliance's quarterly newsletter and get timely information on advancements in science, treatment, and health policy that help you "Live Longer and Love It."